Real world outcomes with elotuzumab-based therapies for patients with relapsed refractory multiple myeloma: a Mayo Clinic experience
Saved in:
| Main Authors: | , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Publishing Group
2025-05-01
|
| Series: | Blood Cancer Journal |
| Online Access: | https://doi.org/10.1038/s41408-025-01310-z |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850270928079945728 |
|---|---|
| author | Ricardo D. Parrondo Saurav Das Hanna Sledge Leif Bergsagel Rafael Fonseca Nelson Leung Prashant Kapoor Morie Gertz Francis Buadi Angela Dispenzieri Jamie Elliott Andre Fernandez Caitlin Flott Asher A. Chanan-Khan Vivek Roy Sikander Ailawadhi |
| author_facet | Ricardo D. Parrondo Saurav Das Hanna Sledge Leif Bergsagel Rafael Fonseca Nelson Leung Prashant Kapoor Morie Gertz Francis Buadi Angela Dispenzieri Jamie Elliott Andre Fernandez Caitlin Flott Asher A. Chanan-Khan Vivek Roy Sikander Ailawadhi |
| author_sort | Ricardo D. Parrondo |
| collection | DOAJ |
| format | Article |
| id | doaj-art-971b24003fd2464eae7f4bb29789fd30 |
| institution | OA Journals |
| issn | 2044-5385 |
| language | English |
| publishDate | 2025-05-01 |
| publisher | Nature Publishing Group |
| record_format | Article |
| series | Blood Cancer Journal |
| spelling | doaj-art-971b24003fd2464eae7f4bb29789fd302025-08-20T01:52:24ZengNature Publishing GroupBlood Cancer Journal2044-53852025-05-011511510.1038/s41408-025-01310-zReal world outcomes with elotuzumab-based therapies for patients with relapsed refractory multiple myeloma: a Mayo Clinic experienceRicardo D. Parrondo0Saurav Das1Hanna Sledge2Leif Bergsagel3Rafael Fonseca4Nelson Leung5Prashant Kapoor6Morie Gertz7Francis Buadi8Angela Dispenzieri9Jamie Elliott10Andre Fernandez11Caitlin Flott12Asher A. Chanan-Khan13Vivek Roy14Sikander Ailawadhi15Division of Hematology-Oncology, Mayo Clinic FloridaDivision of Hematology-Oncology, Mayo Clinic FloridaDivision of Hematology-Oncology, Mayo Clinic FloridaDivision of Hematology-Oncology, Mayo ClinicDivision of Hematology-Oncology, Mayo ClinicDivision of Hematology, Mayo ClinicDivision of Hematology, Mayo ClinicDivision of Hematology, Mayo ClinicDivision of Hematology, Mayo ClinicDivision of Hematology, Mayo ClinicDivision of Hematology-Oncology, Mayo Clinic FloridaDivision of Hematology-Oncology, Mayo Clinic FloridaDivision of Hematology-Oncology, Mayo Clinic FloridaDivision of Hematology-Oncology, Mayo Clinic FloridaDivision of Hematology-Oncology, Mayo Clinic FloridaDivision of Hematology-Oncology, Mayo Clinic Floridahttps://doi.org/10.1038/s41408-025-01310-z |
| spellingShingle | Ricardo D. Parrondo Saurav Das Hanna Sledge Leif Bergsagel Rafael Fonseca Nelson Leung Prashant Kapoor Morie Gertz Francis Buadi Angela Dispenzieri Jamie Elliott Andre Fernandez Caitlin Flott Asher A. Chanan-Khan Vivek Roy Sikander Ailawadhi Real world outcomes with elotuzumab-based therapies for patients with relapsed refractory multiple myeloma: a Mayo Clinic experience Blood Cancer Journal |
| title | Real world outcomes with elotuzumab-based therapies for patients with relapsed refractory multiple myeloma: a Mayo Clinic experience |
| title_full | Real world outcomes with elotuzumab-based therapies for patients with relapsed refractory multiple myeloma: a Mayo Clinic experience |
| title_fullStr | Real world outcomes with elotuzumab-based therapies for patients with relapsed refractory multiple myeloma: a Mayo Clinic experience |
| title_full_unstemmed | Real world outcomes with elotuzumab-based therapies for patients with relapsed refractory multiple myeloma: a Mayo Clinic experience |
| title_short | Real world outcomes with elotuzumab-based therapies for patients with relapsed refractory multiple myeloma: a Mayo Clinic experience |
| title_sort | real world outcomes with elotuzumab based therapies for patients with relapsed refractory multiple myeloma a mayo clinic experience |
| url | https://doi.org/10.1038/s41408-025-01310-z |
| work_keys_str_mv | AT ricardodparrondo realworldoutcomeswithelotuzumabbasedtherapiesforpatientswithrelapsedrefractorymultiplemyelomaamayoclinicexperience AT sauravdas realworldoutcomeswithelotuzumabbasedtherapiesforpatientswithrelapsedrefractorymultiplemyelomaamayoclinicexperience AT hannasledge realworldoutcomeswithelotuzumabbasedtherapiesforpatientswithrelapsedrefractorymultiplemyelomaamayoclinicexperience AT leifbergsagel realworldoutcomeswithelotuzumabbasedtherapiesforpatientswithrelapsedrefractorymultiplemyelomaamayoclinicexperience AT rafaelfonseca realworldoutcomeswithelotuzumabbasedtherapiesforpatientswithrelapsedrefractorymultiplemyelomaamayoclinicexperience AT nelsonleung realworldoutcomeswithelotuzumabbasedtherapiesforpatientswithrelapsedrefractorymultiplemyelomaamayoclinicexperience AT prashantkapoor realworldoutcomeswithelotuzumabbasedtherapiesforpatientswithrelapsedrefractorymultiplemyelomaamayoclinicexperience AT moriegertz realworldoutcomeswithelotuzumabbasedtherapiesforpatientswithrelapsedrefractorymultiplemyelomaamayoclinicexperience AT francisbuadi realworldoutcomeswithelotuzumabbasedtherapiesforpatientswithrelapsedrefractorymultiplemyelomaamayoclinicexperience AT angeladispenzieri realworldoutcomeswithelotuzumabbasedtherapiesforpatientswithrelapsedrefractorymultiplemyelomaamayoclinicexperience AT jamieelliott realworldoutcomeswithelotuzumabbasedtherapiesforpatientswithrelapsedrefractorymultiplemyelomaamayoclinicexperience AT andrefernandez realworldoutcomeswithelotuzumabbasedtherapiesforpatientswithrelapsedrefractorymultiplemyelomaamayoclinicexperience AT caitlinflott realworldoutcomeswithelotuzumabbasedtherapiesforpatientswithrelapsedrefractorymultiplemyelomaamayoclinicexperience AT asherachanankhan realworldoutcomeswithelotuzumabbasedtherapiesforpatientswithrelapsedrefractorymultiplemyelomaamayoclinicexperience AT vivekroy realworldoutcomeswithelotuzumabbasedtherapiesforpatientswithrelapsedrefractorymultiplemyelomaamayoclinicexperience AT sikanderailawadhi realworldoutcomeswithelotuzumabbasedtherapiesforpatientswithrelapsedrefractorymultiplemyelomaamayoclinicexperience |